Tygacil — CareFirst (Caremark)

Community-acquired bacterial pneumonia caused by susceptible isolates of Streptococcus pneumoniae (penicillin-susceptible isolates, including cases with concurrent bacteremia), Haemophilus influenzae, and Legionella pneumophila

Initial criteria

Patient age ≥ 18 years
Used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria
Appropriate cultures obtained before therapy to identify causative organism and confirm susceptibility
Not indicated for diabetic foot infections or hospital-acquired or ventilator-associated pneumonia
May be initiated empirically prior to culture results if serious infection suspected